SCHEMBL8622803

SCHEMBL8622803

CC(C)=CCCCOc1ccc(CCCI)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 3/20 0.41
ALDH1A1 P00352 2/20 0.40
LMNA P02545 2/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40
CYP3A4 P08684 1/20 0.40
MAPK1 P28482 1/20 0.40
CASP1 P29466 1/20 0.40
KMT2A Q03164 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SLCO1B3 Q9NPD5 1/20 0.40
SLCO1B1 Q9Y6L6 1/20 0.40
FFAR1 O14842 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
S1PR1 P21453 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8618406 0.86 LTA4H (0.50) HRH3ALDH1A1LMNAMEN1USP2
SCHEMBL9633219 0.82 TRPV1 (0.34) ALDH1A1LMNACYP3A4CASP1PPARG
SCHEMBL8623162 0.79 LMNA (0.64) LMNAFFAR1L3MBTL1PPARGPPARA
SCHEMBL11452565 0.77 NQO1 (0.56) ALDH1A1LMNASMN1; SMN2L3MBTL1
SCHEMBL9130547 0.75 TRPV1 (0.39) MEN1CYP3A4KMT2APPARGPPARA
SCHEMBL9130559 0.75 TRPV1 (0.39) MEN1CYP3A4KMT2APPARGPPARA
SCHEMBL7625466 0.74 MEN1 (0.59) ALDH1A1LMNAMEN1USP2CYP3A4
SCHEMBL8420664 0.74 KCNA3 (0.59) FFAR1L3MBTL1PPARGS1PR1
SCHEMBL25194799 0.73 LMNA (0.51) ALDH1A1LMNAMEN1CYP3A4KMT2A
SCHEMBL23358307 0.73 HRH3 (0.49) HRH3FFAR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5567841-A ANTICHOLESTEROL AGENT BRISTOL-MYERS SQUIBB COMPANY (US) 1996-10-22 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed